机器学习筛选可从抗生素预防获益的膀胱输尿管反流患儿
该研究基于RIVUR数据开发机器学习模型,预测膀胱输尿管反流患儿复发尿路感染风险,模型AUC为0.82(95%CI 0.74-0.87)。以10%风险降低为 cutoff,仅需对40%患儿使用持续抗生素预防即可实现人群层面最小复发感染;试验集中模型推荐组复发感染率显著低于不一致组(7.5% vs 19.4%,p=0.037)。
要点
- 模型可识别持续抗生素预防获益更大的膀胱输尿管反流患儿亚群。
- 预测因子包括反流级别、血肌酐、种族/性别、既往尿路感染症状和体重百分位。
- 按模型推荐使用持续抗生素预防可减少不必要用药并保留最大获益。
核心结论
- 预测模型可识别更可能从持续抗生素预防获益的膀胱输尿管反流患儿,支持选择性、个体化用药。
研究设计与样本
- 基于RIVUR数据,按4:1随机分为训练集和测试集,开发两个模型分别预测有无持续抗生素预防时的复发尿路感染风险。
- 共纳入607例患儿(558例女性/49例男性,中位年龄12个月),测试集121例。
主要发现
- 复发尿路感染预测模型(持续抗生素预防/安慰剂)的AUC为0.82(95%CI 0.74-0.87)。
- 以10%复发尿路感染风险降低为 cutoff,对40%的膀胱输尿管反流患儿使用持续抗生素预防即可达到人群层面最小复发感染。
- 测试集中51例持续抗生素预防随机分组与模型推荐一致,其复发尿路感染发生率显著低于不一致组(7.5% vs 19.4%,p=0.037)。
关键数值与推荐
- 预测因子包括膀胱输尿管反流级别、血清肌酐、种族/性别、既往尿路感染症状(发热/排尿困难)和体重百分位。
- 模型推荐持续抗生素预防的 cutoff 为复发尿路感染风险降低>10%。
临床怎么用
- 临床可依据模型预测的复发尿路感染风险降低程度,选择性对高风险患儿使用持续抗生素预防,避免全人群用药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Continuous antibiotic prophylaxis reduces the risk of recurrent urinary tract infection by 50% in children with vesicoureteral reflux. However, there may be subgroups in whom continuous antibiotic prophylaxis could be used more selectively. We sought to develop a machine learning model to identify such subgroups. MATERIALS AND METHODS: We used RIVUR data, randomly split into train/test in a 4:1 ratio. Two models were developed to predict recurrent urinary tract infection risk in scenario with and without continuous antibiotic prophylaxis. The test set was then used to validate recurrent urinary tract infection events and the effectiveness of continuous antibiotic prophylaxis. Predicted probabilities of recurrent urinary tract infection were generated from each model. Continuous antibiotic prophylaxis was assigned at various cutoffs of recurrent urinary tract infection risk reduction to evaluate continuous antibiotic prophylaxis effectiveness. RESULTS: A total of 607 patients (558 female/49 male, median age 12 months) were included. Predictors included vesicoureteral reflux grade, serum creatinine, race/gender, prior urinary tract infection symptoms (fever/dysuria) and weight percentiles. The AUC of the prediction model of recurrent urinary tract infection (continuous antibiotic prophylaxis/placebo) was 0.82 (95% CI 0.74-0.87). Using 10% recurrent urinary tract infection risk reduction cutoff, minimal recurrent urinary tract infection per population level can be achieved by giving continuous antibiotic prophylaxis to 40% of patients with vesicoureteral reflux instead of everyone. In a test set (121), 51 patients had continuous antibiotic prophylaxis randomization consistent with model recommendation (continuous antibiotic prophylaxis if recurrent urinary tract infection risk reduction >10%). Recurrent urinary tract infection incidence was significantly lower among this group compared to those whose continuous antibiotic prophylaxis assignment differed from model suggestion (7.5% vs 19.4%, p=0.037). CONCLUSIONS: Our predictive model identifies patients with vesicoureteral reflux who are more likely to benefit from continuous antibiotic prophylaxis, which would allow more selective, personalized use of continuous antibiotic prophylaxis with maximal benefit, while minimizing use in those with least need.
引用
- Bertsimas D, Li M, Estrada C, et al. Selecting Children with Vesicoureteral Reflux Who are Most Likely to Benefit from Antibiotic Prophylaxis: Application of Machine Learning to RIVUR. J Urol. 2020. PMID: 33289598. doi:10.1097/JU.0000000000001445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。